About enovis - ENOV
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
ENOV At a Glance
Enovis Corp.
2711 Centerville Road
Wilmington, Delaware 19808
| Phone | 1-302-252-9160 | Revenue | 2.25B | |
| Industry | Medical Specialties | Net Income | -1,182,531,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 6.663% | |
| Fiscal Year-end | 12 / 2026 | Employees | 7,802 | |
| View SEC Filings |
ENOV Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.676 |
| Price to Book Ratio | 1.023 |
| Price to Cash Flow Ratio | 7.00 |
| Enterprise Value to EBITDA | 9.635 |
| Enterprise Value to Sales | 1.275 |
| Total Debt to Enterprise Value | 0.481 |
ENOV Efficiency
| Revenue/Employee | 288,137.529 |
| Income Per Employee | -151,567.675 |
| Receivables Turnover | 5.077 |
| Total Asset Turnover | 0.526 |
ENOV Liquidity
| Current Ratio | 2.017 |
| Quick Ratio | 1.04 |
| Cash Ratio | 0.061 |
ENOV Profitability
| Gross Margin | 51.87 |
| Operating Margin | 0.134 |
| Pretax Margin | -51.574 |
| Net Margin | -52.603 |
| Return on Assets | -27.65 |
| Return on Equity | -58.369 |
| Return on Total Capital | -41.215 |
| Return on Invested Capital | -35.123 |
ENOV Capital Structure
| Total Debt to Total Equity | 92.608 |
| Total Debt to Total Capital | 48.081 |
| Total Debt to Total Assets | 35.975 |
| Long-Term Debt to Equity | 88.598 |
| Long-Term Debt to Total Capital | 45.999 |